Skip to main content

Table 3 Association of principal components factors with exercise capacity (pVO2)

From: Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy

Factor Overall Non-diabetic Diabetic Interaction p value
Factor beta p value BH p value Factor beta p value Factor beta p value
Baseline
 1 0.857 2E-7 1E-6 0.669 9E-4 1.58 8E-8 0.012
 2 − 0.572 − 0.001 − 0.001 − 1.12 − 0.013 − 0.296 0.088 0.077
 3 − 0.596 4E-4 0.001 − 0.351 0.233 − 0.615 0.002 0.443
 4 − 1.194 2E-8 3E-7 1.43 5E-5 − 0.906 5E-4 0.222
 5 0.623 2E-4 0.001 0.432 0.076 0.822 2E-4 0.234
 6 − 0.215 0.198 0.238      
 7 0.088 0.598 0.653      
 8 0.773 4E-6 1E-5 0.562 0.065 0.811 2E-5 0.473
 9 − 0.314 0.061 0.081      
 10 0.035 0.837 0.837      
 11 − 0.457 0.006 0.011 − 0.443 0.099 − 0.359 0.083 0.803
 12 0.430 0.011 0.017 0.603 0.034 0.238 0.245 0.288
  1. P-values in bold indicate a statistically significant association